Cresco Labs Inc. CRLBF
0.54 USD +0.01 (+1.30%)
Nov 10, 2026, 3:59 PM EST
0.5104 Day range 0.55
0.5104 52-week range 2.30
- YTD
- -55.77%
- 1 year
- -55.77%
- Market cap
- 201.41M
- EPS (ttm)
- -0.26
- YTD return
- -55.77%
- 1-year return
- -55.77%
- Volume
- 248.16K
- Avg volume
- 556.78K
- Open
- 0.523
- Previous close
- 0.537
- Day's range
- 0.5104 – 0.55
- 52-week range
- 0.5104 – 2.30
- Earnings date
- Aug 8, 2024
5D -0.0990 (-15.87%)
Next earnings
Aug 8, 2024
Expected Aug 8, 2024. Consensus EPS estimate -0.01.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 8, 2024 | Sep 1, 2024 | -0.01 | -0.02 | -0.01 | -100.00% |
| Aug 8, 2024 | Jun 1, 2024 | -0.01 | — | — | — |
| Aug 8, 2024 | Jun 1, 2024 | -0.01 | -0.16 | -0.15 | -1,500.00% |
| May 15, 2024 | Mar 1, 2024 | -0.02 | — | — | — |
| May 15, 2024 | Mar 1, 2024 | -0.02 | -0.02 | 0.00 | 0.00% |
| Mar 15, 2024 | Dec 1, 2023 | -0.02 | 0.01 | +0.03 | +150.00% |
News
Cresco Labs Inc. (CRLBF) Q3 2026 Earnings Call Transcript 
Cresco Labs Inc. (CRLBF) Reports Q3 Loss, Misses Revenue Estimates 
Cresco Labs Reports Third Quarter 2026 Financial Results 
Cresco Labs Advances Innovation Pipeline with High Supply SLIPS and Wonder THC Drink Mixes 
Cresco Labs Announces Voting Results of Its Annual General and Special Meeting of Shareholders 
Cresco Labs Inc. (CRLBF) Shareholder/Analyst Call Prepared Remarks Transcript 
Cresco Labs Celebrates Sunnyside Prestonsburg Grand Opening, Marking Major Milestone for Kentucky Medical Cannabis 
Cresco Labs to Report Third Quarter 2026 Financial Results on November 6, 2026 
Cresco Labs Announces Filing of Supplement to Management Information Circular for Annual General and Special Meeting 
3 Cannabis Stocks to Watch Heading Out of September
Your note
Sign in to keep a note on CRLBF — it syncs with the Stock Master app.